NEOLEUKIN THERAPEUTICS INC's ticker is NLTX and the CUSIP is 64049K104. A total of 84 filers reported holding NEOLEUKIN THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 2.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $10,853,000 | -21.7% | 1,501,058 | 0.0% | 0.38% | -22.5% |
| Q2 2021 | $13,855,000 | -25.0% | 1,501,058 | 0.0% | 0.49% | -22.0% |
| Q1 2021 | $18,478,000 | -12.7% | 1,501,058 | 0.0% | 0.63% | -7.8% |
| Q4 2020 | $21,165,000 | +17.5% | 1,501,058 | 0.0% | 0.68% | +9.3% |
| Q3 2020 | $18,013,000 | +7.5% | 1,501,058 | +48.7% | 0.62% | -15.6% |
| Q2 2020 | $16,754,000 | +45.9% | 1,009,255 | 0.0% | 0.74% | -5.9% |
| Q1 2020 | $11,485,000 | -7.6% | 1,009,255 | 0.0% | 0.78% | +11.4% |
| Q4 2019 | $12,434,000 | – | 1,009,255 | – | 0.70% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 1,386,300 | $19,547,000 | 2.55% |
| EcoR1 Capital, LLC | 3,122,704 | $44,030,000 | 2.37% |
| Redmile Group, LLC | 4,131,869 | $58,259,000 | 0.70% |
| Boxer Capital, LLC | 1,501,058 | $21,165,000 | 0.68% |
| HighVista Strategies LLC | 69,727 | $983,000 | 0.63% |
| Baker Brothers Advisors | 3,821,740 | $53,887,000 | 0.20% |
| Highland Private Wealth Management | 93,998 | $1,326,000 | 0.12% |
| Sio Capital Management, LLC | 38,312 | $540,000 | 0.11% |
| Point72 Asset Management, L.P. | 1,195,725 | $16,860,000 | 0.08% |
| Granahan Investment Management | 246,299 | $3,473,000 | 0.08% |